companydata.dkZelandia Life Science R&D Consulting ApS: Financial statements 2024
CVR: 40206051
Zelandia Life Science R&D Consulting ApS (CVR 40206051) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 876,542 and a net result of DKK 670,851 compared with DKK 768,036 the year before. That is a decrease of 9.2% compared with the year before. Equity amounted to DKK 1,310,971. The solvency ratio was 65.5%. The company had 1 employee in the financial year.
- Gross Profit
- 876,542 kr.
- Profit/Loss
- 670,851 kr.
- Equity
- 1,310,971 kr.
- Total Assets
- 2,001,640 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 877 t. | 671 t. | 1.3 mio. | 1 |
| 2023 | - | 965 t. | 768 t. | 940 t. | - |
| 2022 | - | -78 t. | -92 t. | 172 t. | - |
| 2021 | - | 830 t. | 642 t. | 764 t. | - |
| 2020 | - | 307 t. | 236 t. | 322 t. | - |
How creditworthy is Zelandia Life Science R&D Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Zelandia Life Science R&D Consulting ApS has published its annual report for 2023. Gross profit came to DKK 965,311, and the net result was DKK 768,036.
About Zelandia Life Science R&D Consulting ApS
Zelandia Life Science R&D Consulting ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kristian Tage Hansen. The company is owned by KTHolding ApS. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580.